Assessing ROSE For Adequacy of EBUS-TBNA Compared with a Direct-to-cell Block Approach as a Response to the COVID-19 Pandemic

Xing Zhao, MD , Paul Boothe, MD , Syeda Mahrukh Hussnain Naqvi, MD, MPH , Evita Henderson-Jackson, MD , Nancy Melaa , Barbara A. Centeno, MD , Amit Tandon, MD , Marilyn M. Bui, MD, PhD

Journal of the American Society of Cytopathology
Volume 11, Issue 6, November-December 2022, p368-374

eJournal Contributing Author: 
Swikrity U Baskota, MD